A man with severe rheumatic trivalvular disease was treated with surgical implantation
of mechanical aortic and mitral prostheses at the age of 30 years and tricuspid bioprosthesis
at the age of 50 years. At 61 years of age, he developed severe symptomatic tricuspid
regurgitation due to bioprosthesis degeneration and was judged at very high risk for
a third surgical approach. The investigators describe the successful transfemoral
positioning of a 29-mm Edwards SAPIEN XT percutaneous valve inside the degenerated
tricuspid prosthesis, with excellent acute results and no major complications. In
conclusion, percutaneous valve-in-valve treatment of degenerated bioprostheses is
feasible by the transfemoral route and may be of assistance in very selected patients
at high surgical risk.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
Greif M, Schramm R, Steinbeck G, Hagl C, Schmitz C, Kupatt C. Transfemoral access for valve in valve implantation of an Edwards SAPIEN XT valve in a stenotic tricuspid bioprosthesis under fluoroscopic guidance. Can J Cardiol. In press.
- Transfemoral implantation of an Edwards SAPIEN valve in a tricuspid bioprosthesis without fluoroscopic landmarks.Eurointervention. 2012; 7: 1336-1339
- Percutaneous re-revalvulation of the tricuspid valve.Catheter Cardiovasc Interv. 2011; 77: 692-695
- Percutaneous Edwards SAPIEN valve implantation in the tricuspid position: case report and review of literature.Eurointervention. 2012; 8: 628-633
Article info
Publication history
Published online: August 05, 2013
Accepted:
May 14,
2013
Received in revised form:
May 14,
2013
Received:
April 24,
2013
Footnotes
See page 1053 for disclosure information.
Identification
Copyright
© 2013 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
